Bodhi Tree Biotechnology (BDTB) Cash & Equivalents (2024 - 2025)
Bodhi Tree Biotechnology (BDTB) reported Cash & Equivalents of $47366.0 for Q4 2025, down 75.62% year-over-year from $194293.0 in Q4 2024, and down 56.71% quarter-over-quarter from $109404.0 in Q3 2025.
Bodhi Tree Biotechnology (BDTB) Cash & Equivalents (2024 - 2025) Analysis & Trends
Bodhi Tree Biotechnology (BDTB) has 2 years of Cash & Equivalents data on file, last reported at $47366.0 in Q4 2025.
- Cash & Equivalents for Q4 2025 came in at $47366.0, down 75.62% year-over-year; the trailing twelve-month figure through Dec 2025 was $47366.0 (down 75.62% YoY), and the FY2025 annual result was $109404.0, down 57.85% from the prior year.
- Cash & Equivalents slipped to $47366.0 in Q4 2025 per BDTB's latest filing, from $109404.0 in the prior quarter.
- Over five years, Cash & Equivalents peaked at $259570.0 in Q3 2024 and troughed at $47366.0 in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 47,366.00 |
| Sep 30, 2025 | 109,404.00 |
| Jun 30, 2025 | 119,516.00 |
| Mar 31, 2025 | 144,165.00 |
| Dec 31, 2024 | 194,293.00 |
| Sep 30, 2024 | 259,570.00 |